Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Burning Rock Biotech (BNR) Long-Term Investments: 2019-2024

Historic Long-Term Investments for Burning Rock Biotech (BNR) over the last 4 years, with Sep 2024 value amounting to $35,000.

  • Burning Rock Biotech's Long-Term Investments fell 90.96% to $35,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $35,000, marking a year-over-year decrease of 90.96%. This contributed to the annual value of $47,000 for FY2023, which is 53.00% down from last year.
  • Per Burning Rock Biotech's latest filing, its Long-Term Investments stood at $35,000 for Q3 2024, which was up 2.94% from $34,000 recorded in Q2 2024.
  • Over the past 5 years, Burning Rock Biotech's Long-Term Investments peaked at $644,000 during Q3 2022, and registered a low of $34,000 during Q1 2024.
  • In the last 3 years, Burning Rock Biotech's Long-Term Investments had a median value of $109,000 in 2022 and averaged $237,818.
  • As far as peak fluctuations go, Burning Rock Biotech's Long-Term Investments surged by 390.98% in 2023, and later slumped by 94.32% in 2024.
  • Quarterly analysis of 5 years shows Burning Rock Biotech's Long-Term Investments stood at $217,000 in 2020, then tumbled by 34.10% to $143,000 in 2021, then tumbled by 30.07% to $100,000 in 2022, then plummeted by 53.00% to $47,000 in 2023, then plummeted by 90.96% to $35,000 in 2024.
  • Its last three reported values are $35,000 in Q3 2024, $34,000 for Q2 2024, and $34,000 during Q1 2024.